Picture of aap Implantate AG logo

AAQ1 aap Implantate AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: AAP Implantate FY EBITDA Loss Of EUR 4.8 Mln

April 30 (Reuters) - AAP IMPLANTATE AG  AAQ1k.DE :
    * VISIBLE RESULTS UNDER RESTRUCTURING WITH SIGNIFICANTLY
IMPROVED
RECURRING EBITDA (+28%) IN CHALLENGING TIMES OF COVID-19
PANDEMIC
    * FY EBITDA LOSS -4.8 MILLION EUR VERSUS -5.1 MILLION EUR
LOSS
YEAR AGO
    * FY SALES 9.3 MILLION EUR
    * AAP AIMS TO RETURN TO GROWTH PATH IN FINANCIAL YEAR 2021
    * EXPECTS SALES BETWEEN EUR 12.0 MILLION AND EUR 15.0
MILLION,
WHICH CORRESPONDS TO A SIGNIFICANT GROWTH RATE OF +29 TO +61% IN
2021
    * AIMS TO ACHIEVE POSITIVE EBITDA IN OPERATIVE TRAUMA
BUSINESS FOR
FIRST TIME IN FINANCIAL YEAR 2021
    * EXPECTS EBITDA OF EUR -5.5 MILLION TO EUR -3.5 MILLION FOR
CURRENT YEAR

Source text for Eikon:  ID:nEQ29LPDGa 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on aap Implantate AG

See all news